Skip to main content
. 2015 Jan 29;58(5):2091–2113. doi: 10.1021/jm5019093

Table 6. Inhibition of HAT-Catalyzed Histone Acetylation by Select Compounds Using an Orthogonal [3H]-Acetyl-CoA HAT Assaya.

ID Rtt109 HTS IC50 (μM)b slot blot activity (125 μM)b Rtt109 IC50 (μM) (−) DTT p300 IC50 (μM) (−) DTT Gcn5 IC50 (μM) (−) DTT (+) DTT IC50 effectc
1a 8.8 P 15 (11–22) 7.5 (3.0–19) 11 (4.6–26) increase
1i 6 P 4.6 (2.9–7.2) 6.2 (1.8–21) 20 (9.3–44) increase
1j 6.6 P 3.4 (1.9–6.2) 6.2 (3.8–10) 3.7 (2.8–4.8) increase
1k 4.6 P 6.1 (4.1–12) 11 (3.1–38) 11 (5.3–22) increase
2a 2.8 P 3.9 (2.7–5.6) 2.2 (1.7–2.9) 4.6 (3.4–6.3) increase
2e 2.3 Y 0.77 (0.67–1.1) 1.1 (0.7–1.6) 1.6 (0.7–3.9) increase
3a 2.7 Y 0.81 (0.59–1.1) 1.9 (1.4–2.5) 7.5 (5.3–11) increase
3d 2.7 Y 0.64 (0.55–1.3) 1.8 (1.4–2.4) 5.3 (3.9–7.2) increase
3f 3.5 Y 1.7 (1.5–2.2) 2.0 (1.6–2.5) 8.1 (5.8–11) increase
4a 15 P 3.9 (3.1–5.0) 3.7 (1.1–13) 27 (12–61)) increase
4b 17 P 1.2 (0.7–2.1) 2.8 (1.5–5.2) 6.7 (2.7–16) increase
4e 11 Y 8.6 (4.6–16) 9.8 (7.1–14) 27 (10–70) increase
6a NA Y 0.52 (0.45–1.7) 1.0 (0.9–1.2) 0.65 (0.3–1.2) increase
6b 1.5 Y 0.67 (0.63–1.4) 0.51 (0.40–1.4) 2.5 (1.7–3.8) increase
6c NA Y 0.15 (0.12–0.51) 0.66 (0.57–1.3) 1.3 (0.9–1.9) increase
6d 3.9 Y 4.3 (3.1–6.0) 3.1 (2.6–3.7) 4.3 (2.3–7.7) increase
6e 2.5 Y 1.6 (1.2–2.1) 1.8 (1.3–2.5) 1.2 (0.7–1.9) increase
6f 0.91 Y 1.7 (1.4–1.9) 1.1 (0.7–1.6) 5.2 (4.0–6.7) increase
6y NA Y 0.13 (0.12–0.64) 0.33 (0.30–2.3) 1.2 (0.9–1.7) increase
CPM   Y 0.26 (0.20–0.27) 0.26 (0.23–0.35) 1.1 (0.9–1.2) increase
garcinol 13d Y 3.5 (3.3–3.8) 1.7 (0.9–3.1) 2.6 (1.4–4.9) none
fluconazole inactive inactive inactive inactive inactive none
a

In parentheses are the 95% confidence intervals for the IC50 values.

b

Data from Tables 15

c

Compounds tested identically in the presence of 1 mM DTT; results similar versus Rtt109-Vps75, p300, and Gcn5; typically <20% inhibition was observed at 125 μM final compound concentrations.

d

Previously published value.42